logo
中 / EN
  • Home
  • About Us
    Corporate Overview Founders Scientific Committee Subsidiary Company Honor
  • Partnership
    Partnership Partner
  • Scientific Research
    Pipeline Publications
  • News
    Company News Media Information
  • Investor Relations
  • Careers
  • Contact Us
Logo
  • Home
  • About Us
    • Corporate Overview
    • Founders
    • Scientific Committee
    • Subsidiary Company
    • Honor
  • Strategic Cooperation
    • Partnership
    • Partner
  • Scientific Research
    • Pipeline
    • Publications
  • News
    • Company News
    • Media Information
  • Investor Relations
  • Careers
  • Contact Us
CN EN
Scientific Research > Publications
  • Pipeline
  • Publications
Publications
  • Pipeline
  • Publications
  • 2019-04-10

    First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers

  • 2017-12-18

    Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells

  • 2016-06-02

    A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells

  • 2015-09-10

    A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/ Jak2/Stat3 pathway

  • 2014-04-06

    Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish

  • 2013-06-11

    A novelanticanceragentBroussoflavonolBdownregulatesestrogen receptor(ER)-α36 expressionandinhibitsgrowthofER-negativebreast cancer MDA-MB-231cells

  • 2011-11-02

    ER-a36, a novel isoform of ER-a66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast

  • 2011-08-25

    A positive cross-regulation of HER2 and ER- 36 controls ALDH1 positive breast cancer cells

  • 2|15
firstprev123456789nextlast
Copyright © Beijing Shenogen Pharmaceutical Technology Co., Ltd ICP:17000375
Follow Us: